Revolution Medicines, Inc. (RVMD)
102.02
-0.13
(-0.13%)
USD |
NASDAQ |
Feb 27, 16:00
102.15
+0.13
(+0.13%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (TTM) : 978.68M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.71B |
| AbbVie, Inc. | 9.096B |
| Insmed, Inc. | 771.09M |
| Travere Therapeutics, Inc. | 206.01M |